Literature DB >> 23545411

Mammalian HECT ubiquitin-protein ligases: biological and pathophysiological aspects.

Martin Scheffner1, Sharad Kumar.   

Abstract

Members of the HECT family of E3 ubiquitin-protein ligases are characterized by a C-terminal HECT domain that catalyzes the covalent attachment of ubiquitin to substrate proteins and by N-terminal extensions of variable length and domain architecture that determine the substrate spectrum of a respective HECT E3. Since their discovery in 1995, it has become clear that deregulation of distinct HECT E3s plays an eminent role in human disease or disease-related processes including cancer, cardiovascular and neurological disorders, viral infections, and immune response. Thus, a detailed understanding of the structure-function aspects of HECT E3s as well as the identification and characterization of the substrates and regulators of HECT E3s is critical in developing new approaches in the treatment of respective diseases. In this review, we summarize what is currently known about mammalian HECT E3s, with a focus on their biological functions and roles in pathophysiology.This article is part of a Special Issue entitled: Ubiquitin-Proteasome System. Guest Editors: Thomas Sommer and Dieter H. Wolf.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Disease; HECT domain; Signaling; Ubiquitin ligase; Ubiquitination

Mesh:

Substances:

Year:  2013        PMID: 23545411     DOI: 10.1016/j.bbamcr.2013.03.024

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  126 in total

1.  The MLLE domain of the ubiquitin ligase UBR5 binds to its catalytic domain to regulate substrate binding.

Authors:  Juliana Muñoz-Escobar; Edna Matta-Camacho; Guennadi Kozlov; Kalle Gehring
Journal:  J Biol Chem       Date:  2015-07-29       Impact factor: 5.157

Review 2.  CNF1-like deamidase domains: common Lego bricks among cancer-promoting immunomodulatory bacterial virulence factors.

Authors:  Mengfei Ho; Amel Mettouchi; Brenda A Wilson; Emmanuel Lemichez
Journal:  Pathog Dis       Date:  2018-07-01       Impact factor: 3.166

3.  A conformational switch regulates the ubiquitin ligase HUWE1.

Authors:  Bodo Sander; Wenshan Xu; Martin Eilers; Nikita Popov; Sonja Lorenz
Journal:  Elife       Date:  2017-02-14       Impact factor: 8.140

Review 4.  ITCH as a potential therapeutic target in human cancers.

Authors:  Qing Yin; Clayton J Wyatt; Tao Han; Keiran S M Smalley; Lixin Wan
Journal:  Semin Cancer Biol       Date:  2020-03-10       Impact factor: 15.707

5.  A Tunable Brake for HECT Ubiquitin Ligases.

Authors:  Zan Chen; Hanjie Jiang; Wei Xu; Xiaoguang Li; Daniel R Dempsey; Xiangbin Zhang; Peter Devreotes; Cynthia Wolberger; L Mario Amzel; Sandra B Gabelli; Philip A Cole
Journal:  Mol Cell       Date:  2017-05-04       Impact factor: 17.970

6.  Fitting WWP-1 in the dietary restriction network.

Authors:  Andrea C Carrano; Tony Hunter
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 7.  NEDD4-2 (NEDD4L): the ubiquitin ligase for multiple membrane proteins.

Authors:  Pranay Goel; Jantina A Manning; Sharad Kumar
Journal:  Gene       Date:  2014-11-26       Impact factor: 3.688

8.  Genome-wide identification and characterization of the apple (Malus domestica) HECT ubiquitin-protein ligase family and expression analysis of their responsiveness to abiotic stresses.

Authors:  Jianing Xu; Shanshan Xing; Haoran Cui; Xuesen Chen; Xiaoyun Wang
Journal:  Mol Genet Genomics       Date:  2015-10-28       Impact factor: 3.291

Review 9.  Ubiquitin-proteasome signaling in lung injury.

Authors:  Natalia D Magnani; Laura A Dada; Jacob I Sznajder
Journal:  Transl Res       Date:  2018-04-23       Impact factor: 7.012

10.  Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease.

Authors:  Carmen Muñoz-Ballester; Arnaud Berthier; Rosa Viana; Pascual Sanz
Journal:  Biochim Biophys Acta       Date:  2016-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.